Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- UTOBRAIN SEMINAR
October 24, 2005
- Korosho to Include MOF's Viewpoints in Its Healthcare Reform Plan Proposal for FY2006
October 24, 2005
- Takeda to Take the Offensive in Marketing Actos
October 17, 2005
- JGPMA Member Companies Report Overall Declines in Profits
October 17, 2005
- MCHC Created on Oct. 3 with MCC and MPC as Core Members
October 17, 2005
- BUSINESS NEWS IN BRIEF -1-
October 17, 2005
- BUSINESS NEWS IN BRIEF -2-
October 17, 2005
- SEMINAR
October 17, 2005
- Betaferon Protects against Progression to Multiple Sclerosis: Schering AG
October 17, 2005
- R&D NEWS IN BRIEF
October 17, 2005
- SURVEY 2 articles
October 17, 2005
- PMDA Monitors ADRs under Anticancer Combination Therapies
October 17, 2005
- New Chuikyo Starts Full Discussions
October 17, 2005
- MEDICAL DEVICE NEWS IN BRIEF
October 17, 2005
- Discord within Gov't on Control of Medical Expenditure
October 17, 2005
- SELF-MEDICATION NEWS IN BRIEF
October 17, 2005
- Japan Is Not Wasting So Many Resources in Healthcare: Dr Fujii
October 17, 2005
- NEW PRODUCTS
October 17, 2005
- Medical Fees Must Be Raised for Better Healthcare: JMA President
October 17, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 17, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…